RESTART LIFE SCIENCES CORP.

CSE:HEAL Canada Healthcare — Biotechnology

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of c…

Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the full company research view.
Results 2026-05-26
Interim financial statements/report – English.pdf
Results 2026-05-26
Interim MD&A - English.pdf
Transactions 2026-05-21 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-05-21 Financing
Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering
News release - English.pdf
Ownership 2026-05-21
Loutskou, Steve bought +$50k
Insider trading – 2026-05-21
1 insider · +$50k net
News 2026-05-20
Restart Life Sciences Corp. Announces Operational Update Regarding Strategic Trademark Licensing Agreement
Material change report - English.pdf
Ownership 2026-05-20
2 insiders · +$147k net
Insider trading – 2026-05-20
2 insiders · +$147k net
News 2026-05-15
Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio
News release - English.pdf
News 2026-05-14
Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market
News release - English.pdf
Transactions 2026-05-09 Financing
Restart Life Sciences Announces Dedicated Purchase Order Financing through Private Placement Offering
News release - English.pdf
Ownership 2026-05-06
Harrycharran, Khavita bought +$6k
Insider trading – 2026-05-06
1 insider · +$6k net
Results 2026-05-05
Restart Life Sciences reports Holy Crap Foods revenue gains of 46% in wholesale and 32% via Amazon channels YoY
News release - English.pdf
News 2026-04-30
Restart Life Advances Holy Crap™ Growth Strategy with New Protein SKU Nearing Commercialization
News release - English.pdf
Ownership 2026-04-30
Harrycharran, Khavita bought +$2k
Insider trading – 2026-04-30
1 insider · +$2k net
News 2026-04-28
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada's Digital Marketplace
News release - English.pdf
Ownership 2026-04-27
Loutskou, Steve bought +$238
Insider trading – 2026-04-27
1 insider · +$238 net
Results 2026-04-24
Annual MD&A - English.pdf
Results 2026-04-24
Audited annual financial statements – English.pdf
Results 2026-04-23
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Reports Over 500,000 Units Sold, Highlighting Strong Consumer Adoption
News release - English.pdf
Results 2026-04-22
Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio
News release - English.pdf
Results 2026-04-22
Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio
News release - English.pdf
News 2026-03-11
Restart Life Highlights Certified Manufacturing Platform to Drive Margin Expansion and Distribution Growth
News release - English.pdf
Transactions 2026-03-10
Other material contracts - English.pdf
Transactions 2026-03-04
Other material contracts - English.pdf
News 2026-03-03
Restart Life Announces Collaboration with University of Manitoba's Centre for Food Technology and Research
News release - English.pdf
Transactions 2026-02-27 M&A
Restart Life Sciences Corp. Closes Acquisition of Holy Crap Foods
Material change report - English.pdf
Transactions 2026-02-27 M&A
Restart Life Sciences Closes Acquisition of Holy Crap Foods
News release - English.pdf
Transactions 2026-02-13 M&A
Restart Life Sciences Corp. Executes Definitive Agreement to Acquire Holy Crap Foods Inc.
News release - English.pdf
Transactions 2026-01-11 M&A
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
Material change report - English.pdf
News 2025-12-23
Report of exempt distribution (45-106F1).pdf
Transactions 2025-12-22 M&A
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
News release - English.pdf
Transactions 2025-12-22 Financing
Restart Life receives aggregate gross proceeds of approximately $590,000 from warrant exercises and loan
News release - English.pdf
Transactions 2025-12-18 Financing
Restart Life Sciences Corp. Closes Over-Subscribed Second Tranche Private Placement
Material change report - English.pdf
Transactions 2025-12-18 Financing
Restart Life Closes Over-Subscribed Second Tranche Financing
News release - English.pdf
News 2025-12-17
Restart Life Announces Food Technology and Research Studies
News release - English.pdf
Transactions 2025-12-16 Financing
Restart Life Sciences Announces Closing First Tranche of Financing
Material change report - English.pdf
News 2025-12-11
Report of exempt distribution (45-106F1).pdf
Transactions 2025-12-05 Financing
Restart Life Sciences Announces Closing First Tranche of Financing
News release - English.pdf
Results 2025-11-26 Financials
Interim MD&A - English.pdf
Results 2025-11-26 Financials
Interim financial statements/report – English.pdf
News 2025-11-12
News release - English.pdf
Results 2025-08-22 Financials
Interim MD&A - English.pdf
Results 2025-08-22 Financials
Interim financial statements/report – English.pdf
News 2025-08-21
News release - English.pdf
News 2025-07-08
Offering document - English.pdf
News 2025-07-08
News release - English.pdf
News 2025-06-11
News release - English.pdf
News 2025-06-05
News release - English.pdf

Showing 48 of 62 items in this period.